| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.01B | — | +5.3% |
| Gross Profit | $75.3M | — | -1.0% |
| R&D Expense | $17.6M | — | +4.7% |
| SG&A Expense | $64.2M | — | -4.0% |
| Operating Income | -$8.8M | — | +15.3% |
| Pre-tax Income | -$8.7M | — | +7.5% |
| Income Tax | -$3.6M | — | -312.6% |
| Net Income | -$5.1M | — | +53.8% |
| EPS (Basic) | -$0.03 | — | +57.1% |
| EPS (Diluted) | -$0.03 | — | +57.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $122.1M | -1.7% | +5.6% |
| Accounts Receivable | $123.2M | +13.2% | +18.4% |
| Current Assets | $328.7M | +7.8% | +9.2% |
| Total Assets | $467.2M | +5.6% | +7.2% |
| Current Liabilities | $211.3M | +5.8% | -5.6% |
| Total Liabilities | $211.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $20.6M | — | -48.4% |
| Capital Expenditures | $2.5M | — | -1.5% |
| Investing Cash Flow | -$2.1M | — | +85.3% |
| Financing Cash Flow | -$7.9M | — | +35.3% |
| Free Cash Flow | $18.1M | — | -51.6% |
| -5.6% |
| Stockholders' Equity | $255.9M | +5.4% | +20.7% |